Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Massimo Volpe
  • Clinical Interventions in Aging, October 2015, Dove Medical Press
  • DOI: 10.2147/cia.s88195

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: Prof. Stefano Omboni